ZNZeus Jaren Nair

Zeus Jaren Nair

*This is an algorithmically generated author record based on publicly available information.

Zeus Jaren Nair has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin

    by Cristina Colomer-Winter, Zeus J. Nair, Jerome Y. J. Chua, Soukayna Jabli, Mélanie Roch, Amaury Cazenave-Gassiot, Roberto Sierra, Diego O. Andrey, Shu-Sin Chng, Kimberly A. Kline

    Daptomycin is a last resort antibiotic used to treat vancomycin-resistant enterococcal infections, but daptomycin resistance (DAP R ) arises quickly during treatment. Resistance is due to sequential acquisition of point mutations in the two-component system LiaFSR and in cardiolipin synthases and is associated with alteration of phospholipid and glycolipid membrane composition. The molecular mechanisms underlying these lipid changes are currently unknown. Similarly, it is unclear why mutations in liaFSR occur prior to mutations in cls . We found that Enterococcus faecalis remodels membrane composition as a phenotypic response to daptomycin that parallels the membrane composition of DAP R strains. The enrichment in glycolipids that follows antibiotic exposure is due to LtaS1, the main lipoteichoic acid (LTA) synthase of E. faecalis . LTA production is primarily governed by LiaFSR and SapRS, which directly couples antibiotic sensing with membrane lipid remodeling. Together, our results provide a unifying mechanism that drives phenotypic membrane fortification in a gram-positive pathogen which simultaneously predisposes the cell to acquire genetic high-level daptomycin resistance.


  • Open Access

    A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin

    by Cristina Colomer-Winter, Zeus J. Nair, Jerome Y. J. Chua, Soukayna Jabli, Mélanie Roch, Amaury Cazenave-Gassiot, Roberto Sierra, Diego O. Andrey, Shu-Sin Chng, Kimberly A. Kline

    Daptomycin is a last resort antibiotic used to treat vancomycin-resistant enterococcal infections, but daptomycin resistance (DAP R ) arises quickly during treatment. Resistance is due to sequential acquisition of point mutations in the two-component system LiaFSR and in cardiolipin synthases and is associated with alteration of phospholipid and glycolipid membrane composition. The molecular mechanisms underlying these lipid changes are currently unknown. Similarly, it is unclear why mutations in liaFSR occur prior to mutations in cls . We discovered that Enterococcus faecalis remodels membrane composition as a phenotypic response to daptomycin that parallels the membrane composition of DAP R strains. The enrichment in glycolipids that follows antibiotic exposure is due to LtaS1, the main LTA synthase of E. faecalis . Moreover, LtaS1 activity is governed by a network of two-component systems formed by LiaFSR, SapRS, and BsrRS that couple antibiotic sensing with membrane lipid remodeling. Together, our results provide a unifying mechanism that drives phenotypic membrane fortification in a Gram-positive pathogen which simultaneously predisposes the cell to acquire genetic high-level daptomycin resistance. Significance Statement: Daptomycin is the preferred alternative to treat vancomycin-resistant Enterococcus infections. However, the efficacy of daptomycin is limited by the acquisition of daptomycin resistance. Alterations in lipid membrane composition represent a conserved strategy to fortify the Gram-positive membrane. We discovered that E. faecalis phenotypically remodels membrane composition in response to daptomycin and that the enrichment in glycolipids is dependent on LTA synthesis. We expand our limited knowledge of enterococcal LTA synthases, confirming LtaS1 as the main LTA synthase and placing LTA biogenesis under control of a network of antibiotic-responsive two-component systems. Our work provides a molecular explanation for the sequential evolution of daptomycin resistance and may support the use of existing LtaS inhibitors to prevent acquisition of daptomycin resistance.


  • Open Access

    An essential protease,FtsH, influences daptomycin resistance acquisition inEnterococcus faecalis

    by Zeus Jaren Nair, Iris Hanxing Gao, Aslam Firras, Kelvin Kian Long Chong, Eric D. Hill, Pei Yi Choo, Cristina Colomer‐Winter, Qingyan Chen, Caroline Manzano, Kevin Pethe, et al.

    Daptomycin is a last‐line antibiotic commonly used to treat vancomycin‐resistant Enterococci, but resistance evolves rapidly and further restricts already limited treatment options. While genetic determinants associated with clinical daptomycin resistance (DAPR) have been described, information on factors affecting the speed of DAPRacquisition is limited. The multiple peptide resistance factor (MprF), a phosphatidylglycerol‐modifying enzyme involved in cationic antimicrobial resistance, is linked to DAPRin pathogens such as methicillin‐resistantStaphylococcus aureus. SinceEnterococcus faecalisencodes two paralogs ofmprFand clinical DAPRmutations do not map tomprF, we hypothesized that functional redundancy between the paralogs preventsmprF‐mediated resistance and masks other evolutionary pathways to DAPR. Here, we performed in vitro evolution to DAPRinmprFmutant background. We discovered that the absence ofmprFresults in slowed DAPRevolution and is associated with inactivating mutations inftsH, resulting in the depletion of the chaperone repressor HrcA. We also report thatftsHis essential in the parental, but not in the ΔmprF, strain where FtsH depletion results in growth impairment in the parental strain, a phenotype associated with reduced extracellular acidification and reduced ability for metabolic reduction. This presents FtsH and HrcA as enticing targets for developing anti‐resistance strategies.


  • Open Access

    An essential protease, FtsH, influences daptomycin resistance acquisition in Enterococcus faecalis

    by Zeus Jaren Nair, Iris Hanxing Gao, Aslam Firras, Kelvin Kian Long Chong, Pei Yi Choo, Kevin Pethe, Kimberly A. Kline

    Summary: Daptomycin is a last-line antibiotic commonly used to treat vancomycin resistant Enterococci, but resistance evolves rapidly and further restricts already limited treatment options. While genetic determinants associated with clinical daptomycin resistance (DAP R ) have been described, information on factors affecting the speed of DAP R acquisition is limited. The multiple peptide resistance factor (MprF), a phosphatidylglycerol modifying enzyme involved in cationic antimicrobial resistance, is linked to DAP R in pathogens such as methicillin-resistant Staphylococcus aureus . Since Enterococcus faecalis encodes two paralogs of mprF and clinical DAP R mutations do not map to mprF, we hypothesized that functional redundancy between the paralogs prevents mprF -mediated resistance and masks other evolutionary pathways to DAP R . Here we performed in vitro evolution to DAP R in mprF mutant background. We discovered that the absence of mprF results in slowed DAP R evolution and is associated with inactivating mutations in ftsH resulting in the depletion of the chaperone repressor HrcA. We also report that ftsH is essential in the parental, but not in the Δ mprF , strain where FtsH depletion results in growth impairment in the parental strain, a phenotype associated with reduced glycolysis and reduced ability for metabolic reduction. This presents FtsH and HrcA as enticing targets for developing anti-resistance strategies. Graphical


  • Open Access

    Depleting cationic lipids involved in antimicrobial resistance drives adaptive lipid remodeling in Enterococcus faecalis

    by Rafi Rashid, Zeus Jaren Nair, Dominic Ming Hao Chia, Kelvin Kian Long Chong, Amaury Cazenave Gassiot, Stewart A. Morley, Doug K. Allen, Swaine L. Chen, Shu Sin Chng, Markus R. Wenk, et al.

    The bacterial cell membrane is an interface for cell envelope synthesis, protein secretion, virulence factor assembly and a target for host cationic antimicrobial peptides (CAMPs). To resist CAMP killing, several Gram-positive pathogens encode the multiple peptide resistance factor (MprF) enzyme that covalently attaches cationic amino acids to anionic phospholipids in the cell membrane. While E. faecalis encodes two mprF paralogs, MprF2 plays a dominant role in conferring resistance to killing by the CAMP human β-defensin 2 (hBD-2) in E. faecalis strain OG1RF. The goal of the current study is to understand the broader lipidomic and functional roles of E. faecalis mprF . We analyzed the lipid profiles of parental wild type and mprF mutant strains and show that while ∆ mprF2 and ∆ mprF1 ∆ mprF2 mutants completely lacked cationic lysyl-phosphatidylglycerol (L-PG), the ∆ mprF1 mutant synthesized ∼70% of L-PG compared to the parent. Unexpectedly, we also observed a significant reduction of PG in ∆ mprF2 and ∆ mprF1 ∆ mprF2 . In the mprF mutants, particularly ∆ mprF1 ∆ mprF2 , the decrease in L-PG and PG is compensated by an increase in the phosphorus-containing lipid, GPDGDAG, and D-ala-GPDGDAG. These changes were accompanied by a downregulation of de novo fatty acid biosynthesis and an accumulation of long-chain acyl-acyl carrier proteins (long-chain acyl-ACPs), suggesting that the suppression of fatty acid biosynthesis was mediated by the transcriptional repressor FabT. Growth in chemically defined media lacking fatty acids revealed severe growth defects in the ∆ mprF1 ∆ mprF2 mutant strain, but not the single mutants, which was partially rescued through supplementation with palmitic and stearic acids. Changes in lipid homeostasis correlated with lower membrane fluidity, impaired protein secretion, and increased biofilm formation in both ∆ mprF2 and ∆ mprF1 ∆ mprF2 , compared to wild type and ∆ mprF1 . Collectively, our findings reveal a previously unappreciated role for mprF in global lipid regulation and cellular physiology, which could facilitate the development of novel therapeutics targeting MprF. Significance Statement: The cell membrane plays a pivotal role in protecting bacteria against external threats, such as antibiotics. Cationic phospholipids such as lysyl-phosphatidyglycerol (L-PG) resist the action of cationic antimicrobial peptides through electrostatic repulsion. Here we demonstrate that L-PG depletion has several unexpected consequences in Enterococcus faecalis , including a reduction of phosphatidylglycerol (PG), enrichment of a phosphorus-containing lipid, reduced fatty acid synthesis accompanied by an accumulation of long-chain acyl-acyl carrier proteins (long chain acyl-ACPs), lower membrane fluidity, and impaired secretion. These changes are not deleterious to the organism as long as exogenous fatty acids are available for uptake from the culture medium. Our findings suggest an adaptive mechanism involving compensatory changes across the entire lipidome upon removal of a single phospholipid modification. Such adaptations must be considered when devising antimicrobial strategies that target membrane lipids.

  • Open Access

    Heme cross-feeding can augment Staphylococcus aureus and Enterococcus faecalis dual species biofilms

    by Jun-Hong Ch’nG, Mugil Muthu, Kelvin K. L. Chong, Jun Jie Wong, Casandra A. Z. Tan, Zachary J. S. Koh, Daniel Lopez, Artur Matysik, Zeus J. Nair, Timothy Barkham, et al.

    The contribution of biofilms to virulence and as a barrier to treatment is well-established for Staphylococcus aureus and Enterococcus faecalis, both nosocomial pathogens frequently isolated from biofilm-associated infections. Despite frequent co-isolation, their interactions in biofilms have not been well-characterized. We report that in combination, these two species can give rise to augmented biofilms biomass that is dependent on the activation of E. faecalis aerobic respiration. In E. faecalis, respiration requires both exogenous heme to activate the cydAB-encoded heme-dependent cytochrome bd, and the availability of O2. We determined that the ABC transporter encoded by cydDC contributes to heme import. In dual species biofilms, S. aureus provides the heme to activate E. faecalis respiration. S. aureus mutants deficient in heme biosynthesis were unable to augment biofilms whereas heme alone is sufficient to augment E. faecalis mono-species biofilms. Our results demonstrate that S. aureus-derived heme, likely in the form of released hemoproteins, promotes E. faecalis biofilm formation, and that E. faecalis gelatinase activity facilitates heme extraction from hemoproteins. This interspecies interaction and metabolic cross-feeding may explain the frequent co-occurrence of these microbes in biofilm-associated infections.


  • Open Access

    The composition and function ofEnterococcus faecalismembrane vesicles

    by Irina Afonina, Brenda Tien, Zeus Nair, Artur Matysik, Ling Ning Lam, Mark Veleba, Augustine Koh Jing Jie, Rafi Rashid, Amaury Cazenave-Gassiot, Marcus Wenk, et al.

    Membrane vesicles (MVs) contribute to various biological processes in bacteria, including virulence factor delivery, antimicrobial resistance, host immune evasion and cross-species communication. MVs are frequently released from the surface of both Gram-negative and Gram-positive bacteria during growth. In some Gram-positive bacteria, genes affecting MV biogenesis have been identified, but the mechanism of MV formation is unknown. In Enterococcus faecalis, a causative agent of life-threatening bacteraemia and endocarditis, neither mechanisms of MV formation nor their role in virulence has been examined. Since MVs of many bacterial species are implicated in host–pathogen interactions, biofilm formation, horizontal gene transfer, and virulence factor secretion in other species, we sought to identify, describe and functionally characterize MVs from E. faecalis. Here, we show that E. faecalis releases MVs that possess unique lipid and protein profiles, distinct from the intact cell membrane and are enriched in lipoproteins. MVs of E. faecalis are specifically enriched in unsaturated lipids that might provide membrane flexibility to enable MV formation, providing the first insights into the mechanism of MV formation in this Gram-positive organism.